Early Detection of Triple Negative Breast Cancer Relapse
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DIAGNOSTIC_TEST: ctDNA monitoring|DIAGNOSTIC_TEST: 68Ga-FAPI-46-PET-CT
Sponsor: Institut Curie
Collaborators: National Research Agency, France|Roche Pharma AG